The FDA approved the fourth natural food color additive this year, but how can you avoid the artificial dyes still out there?

A natural blue food coloring made from gardenia fruit has been approved by the U.S. Food and Drug Administration (FDA).

Eli Lilly and Company (NYSE: LLY) is one of Goldman Sachs’ top healthcare stock picks. On July 9, the company confirmed the ...

Gardenia (genipin) blue is the fourth natural food color additive the FDA has approved this year, but how is it made?

GE HealthCare Technologies Inc. (NASDAQ:GEHC) is one of the best up and coming stocks to invest in now. On June 24, On June ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to treat attention-deficit hyperactivity disorder to include warnings about the ...

The FDA has approved required updates to the labeling of Pfizer’s Comirnaty and Moderna’s Spikevax COVID-19 vaccines to include revised warnings about the risk of myocarditis and pericarditis ...

Developing standards for the conversion of paper labeling to an electronic format is a high priority for FDA. The content and format revisions to the prescribing information are a key component of ...

Incyte (INCY) stock is in focus as the FDA approves a label expansion for the company's cancer medicine Monjuvi to treat follicular lymphoma. Read more here.

FDA approves AbbVie's Mavyret for acute hepatitis C, expanding its use to patients 3 and older with or without cirrhosis after positive trial data.

Get the latest stock analysis from Benzinga? This article FDA Expands AbbVie's Mavyret Label To Include Pediatric Patients With Hepatitis C Infection originally appeared on Benzinga.com ...